Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Vir Biotechnology Inc
(NQ:
VIR
)
8.300
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vir Biotechnology Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
November 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Atea Announces Termination of Strategic Collaboration With Roche Atea...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 17, 2021
Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
November 17, 2021
Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10...
Via
Benzinga
GSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19
November 12, 2021
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have announced topline data from COMET-TAIL Phase 3 trial evaluating sotrovimab delivered...
Via
Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...
Via
Benzinga
3 Vaccine Stocks With Big Opportunities Outside of COVID-19
November 11, 2021
For most of the past two years, all the focus has been on the coronavirus, but these biotechs have big plans to develop inoculations against other diseases, too.
Via
The Motley Fool
Exposures
COVID-19
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Why Vir Biotechnology Stock Is Sliding Today
November 05, 2021
Efficacy results for oral antivirals from Pfizer and Merck are weighing heavily on Vir today.
Via
The Motley Fool
Exposures
COVID-19
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
GlaxoSmithKline Drops Research On Otilimab In COVID-19
October 27, 2021
GlaxoSmithKline Plc (NYSE: GSK), in its Q3 earnings release, revealed that it is stopping the development of otilimab in COVID-19 in patients who are at least 70 years...
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2021
October 25, 2021
Upgrades According to Wedbush, the prior rating for Regions Financial Corp (NYSE:
Via
Benzinga
10 Biggest Price Target Changes For Monday
October 25, 2021
Wells Fargo boosted Bank of America Corporation (NYSE:B...
Via
Benzinga
GlaxoSmithKline: My Top Value Stock For The Week
October 23, 2021
GSK, one of the biggest pharmaceuticals companies in the world, is seeing a lot of success with new drugs and plenty more in the pipeline. Better yet for would-be investors, the stock is still very...
Via
Talk Markets
Moderna Slapped With Sell Rating Despite CDC Authorization For Covid Boosters
October 22, 2021
The CDC authorized boosters from J&J, Moderna and a mix-and-match approach.
Via
Investor's Business Daily
The Next Challenge For Covid Stocks Is Also A Cash Cow For These Companies
October 15, 2021
Companies working on sorely needed Covid treatments are innovating to keep up.
Via
Investor's Business Daily
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
AstraZeneca Plc (NASDAQ: AZN) released top-line data from the TACKLE Phase 3 trial in which its experimental COVID-19 drug has helped cut the risk of severe disease...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 06, 2021
Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market session. The company's market cap stands at $136.9...
Via
Benzinga
Tesla and Merck Give Investors Some Hope
October 04, 2021
Friday’s rally appears to have lost its momentum over the weekend because stock futures are trading lower before Monday’s open. China’s troubled real estate...
Via
Benzinga
54 Biggest Movers From Friday
October 04, 2021
Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc....
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher
October 01, 2021
Toward the end of trading Friday, the Dow traded up 1.49% to 34,346.53 while the NASDAQ rose 0.75% to 14,556.92. The S&P also rose, gaining 1.18% to 4,358.52. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
October 01, 2021
Gainers Biomerica (NASDAQ:BMRA) stock moved upwards by 39.33% to $6.27 during Friday's regular session. As of 12:30 EST, Biomerica's stock is trading at a volume...
Via
Benzinga
Merck Stock Surges Into Buy Zone As Covid Pill Reduces Risk Of Death, Hospitalization
October 01, 2021
Merck said its Covid pill, molnupiravir, cut the risk of death and hospitalization by half.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
Japan's health ministry expert committee has approved GlaxoSmithKline Plc (NYSE: GSK) - Vir Biotechnology Inc's (NASDAQ: VIR) sotrovimab, a COVID-19...
Via
Benzinga
Why Vir Biotechnology Stock Is Sinking This Week
September 24, 2021
Shares fell after an analyst's downgrade.
Via
The Motley Fool
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021
September 22, 2021
Upgrades Argus Research upgraded the previous rating for Simon Property Group Inc (NYSE:
Via
Benzinga
Vir Biotechnology Earnings Perspective: Return On Capital Employed
September 06, 2021
According to Benzinga Pro, during Q2, Vir Biotechnology (NASDAQ:VIR) earned $61.02 million, a 138.46% increase from the preceding quarter. Vir Biotechnology also posted a total of...
Via
Benzinga
Now May Be the Big Moment for These 2 COVID Stocks
September 02, 2021
Their products are seeing a surge in demand.
Via
The Motley Fool
Exposures
COVID-19
9 Health Care Stocks With Unusual Options Alerts In Today's Session
August 23, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.